122 related articles for article (PubMed ID: 37830402)
1. GSH-activatable camptothecin prodrug-loaded gold nanostars coated with hyaluronic acid for targeted breast cancer therapy
Hou Y; Sun B; Li R; Meng W; Zhang W; Jia N; Chen M; Chen J; Tang X
J Mater Chem B; 2023 Oct; 11(41):9894-9911. PubMed ID: 37830402
[TBL] [Abstract][Full Text] [Related]
2. Biotin-decorated hollow gold nanoshells for dual-modal imaging-guided NIR-II photothermal and radiosensitizing therapy toward breast cancer.
Chen Y; Meng W; Chen M; Zhang L; Chen M; Chen X; Peng J; Huang N; Zhang W; Chen J
J Mater Chem B; 2023 Oct; 11(41):10003-10018. PubMed ID: 37843459
[TBL] [Abstract][Full Text] [Related]
3. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
[TBL] [Abstract][Full Text] [Related]
4. Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing.
Ao M; Yu F; Li Y; Zhong M; Tang Y; Yang H; Wu X; Zhuang Y; Wang H; Sun X; Hong X; Chen XD
J Nanobiotechnology; 2021 Oct; 19(1):350. PubMed ID: 34717646
[TBL] [Abstract][Full Text] [Related]
5. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y
Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480
[TBL] [Abstract][Full Text] [Related]
6. Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H
Mu X; Huang Z; Feng W; Zhai M; Wang Y; Zhou D; Zhou X
Theranostics; 2023; 13(1):267-277. PubMed ID: 36593965
[No Abstract] [Full Text] [Related]
7. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
8. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
[TBL] [Abstract][Full Text] [Related]
9. Redox/NIR dual-responsive MoS
Liu J; Li F; Zheng J; Li B; Zhang D; Jia L
J Nanobiotechnology; 2019 Jul; 17(1):78. PubMed ID: 31269964
[TBL] [Abstract][Full Text] [Related]
10. A theranostic prodrug based on FRET for real-time drug release monitoring in response to biothiols.
Hu Y; Zeng F
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():77-85. PubMed ID: 28024642
[TBL] [Abstract][Full Text] [Related]
11. Drug Release from Disulfide-Linked Prodrugs: Role of Thiol Agents.
Lei J; Zhang Q; Jin X; Lu H; Wang S; Li T; Sheng Y; Zhang F; Zheng Y
Mol Pharm; 2021 Jul; 18(7):2777-2785. PubMed ID: 34121410
[TBL] [Abstract][Full Text] [Related]
12. Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release.
Xu Z; Hou M; Shi X; Gao YE; Xue P; Liu S; Kang Y
Biomater Sci; 2017 Feb; 5(3):444-454. PubMed ID: 28058423
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic Acid-Coated Camptothecin Nanocrystals for Targeted Drug Delivery to Enhance Anticancer Efficacy.
Wang J; Muhammad N; Li T; Wang H; Liu Y; Liu B; Zhan H
Mol Pharm; 2020 Jul; 17(7):2411-2425. PubMed ID: 32437163
[TBL] [Abstract][Full Text] [Related]
14. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
[TBL] [Abstract][Full Text] [Related]
15. Synergistic photothermal-photodynamic-chemotherapy toward breast cancer based on a liposome-coated core-shell AuNS@NMOFs nanocomposite encapsulated with gambogic acid.
Li RT; Zhu YD; Li WY; Hou YK; Zou YM; Zhao YH; Zou Q; Zhang WH; Chen JX
J Nanobiotechnology; 2022 May; 20(1):212. PubMed ID: 35524270
[TBL] [Abstract][Full Text] [Related]
16. Reduction-sensitive fluorescence enhanced polymeric prodrug nanoparticles for combinational photothermal-chemotherapy.
Zhang Y; Yang D; Chen H; Lim WQ; Phua FSZ; An G; Yang P; Zhao Y
Biomaterials; 2018 May; 163():14-24. PubMed ID: 29452945
[TBL] [Abstract][Full Text] [Related]
17. A novel carbon-nanodots-based theranostic nano-drug delivery system for mitochondria-targeted imaging and glutathione-activated delivering camptothecin.
Gong X; Wang Z; Zhang L; Dong W; Wang R; Liu Y; Song S; Hu Q; Du F; Shuang S; Dong C
Colloids Surf B Biointerfaces; 2022 Oct; 218():112712. PubMed ID: 35921692
[TBL] [Abstract][Full Text] [Related]
18. Remodeling the Tumor Microenvironment with Core-Shell Nanosensitizer Featuring Dual-Modal Imaging and Multimodal Therapy for Breast Cancer.
Hou YK; Zhang ZJ; Li RT; Peng J; Chen SY; Yue YR; Zhang WH; Sun B; Chen JX; Zhou Q
ACS Appl Mater Interfaces; 2023 Jan; 15(2):2602-2616. PubMed ID: 36622638
[TBL] [Abstract][Full Text] [Related]
19. Novel disulfide bond bridged 7-ethyl-10-hydroxyl camptothecin-undecanoic acid conjugate/human serum albumin nanoparticles for breast cancer therapy.
Zhang Y; Wang J; Liu C; Xing H; Jiang Y; Li X
J Mater Chem B; 2023 Mar; 11(11):2478-2489. PubMed ID: 36843543
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.
Wu X; Sun X; Guo Z; Tang J; Shen Y; James TD; Tian H; Zhu W
J Am Chem Soc; 2014 Mar; 136(9):3579-88. PubMed ID: 24524232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
